07/05/2024 | 07:00 CEST | Group Announcements
Stäfa (Switzerland), May 7, 2024 – Sonova Holding AG, a leading provider of hearing care solutions, today announces upcoming appointments to its Management Board. Lilika Beck, currently Managing Director Connect Hearing Canada in the Audiological Care business, will succeed Martin Grieder as GVP Consumer Hearing, after he passed away in a tragic accident at the beginning of April 2024. Oliver Lux, currently Managing Director Audiological Care Germany, will be appointed GVP Audiological Care, succeeding Christophe Fond, who will pursue a career opportunity outside the hearing care industry after successfully leading Sonova’s Audiological Care business for seven years. Alistair Simpson will join the company as GVP Cochlear Implants to succeed Victoria Carr-Brendel, who has decided to retire from executive roles for personal reasons after successfully leading Sonova’s Cochlear Implants business since 2019.
Arnd Kaldowski, CEO of Sonova, says: “During their tenure at Sonova, Martin, Christophe and Vicky have played important roles in driving Sonova’s overall success, significantly advancing their respective businesses with great passion and ambitions for profitable growth. They have built strong teams and created good foundations for their successors and Sonova. I am very grateful for their dedication and significant contributions to our company over many years.”
For the GVP roles in Consumer Hearing and Audiological Care, Sonova is able to leverage its strong talent pipeline by promoting Lilika Beck and Oliver Lux. Both Lilika and Oliver have delivered strong results at Sonova over many years, with proven commercial expertise, in-depth knowledge of consumer needs and good foundations in operational excellence. They have also demonstrated their leadership capabilities in various senior positions across different regions and businesses at Sonova. The appointments will become effective in June.
Alistair Simpson is an experienced business executive with a successful track record in managing full P&Ls as a General Manager, including leading marketing, sales and R&D functions. He brings longstanding expertise in highly regulated medical devices and has held various senior leadership positions in companies including Johnson & Johnson, Danaher and LivaNova. Alistair will take over the role of GVP Cochlear Implants as of July 1, 2024, after a dedicated immersion period. He will be based in Valencia (California, USA) at the Advanced Bionics headquarters.
Arnd comments: “We are excited that these three experienced leaders join our Management Board. They will enable us to continue the successful strategy execution in the three businesses, aiming to drive profitable growth through innovation and expansion of our customer access. I would like to congratulate Lilika, Oliver and Alistair on their appointments and look forward to working with them closely.”
– End –